Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Leukemia, Myeloid, Acute 30Myelodysplastic Syndromes 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Multiple Myeloma 9Leukemia, Myelomonocytic, Chronic 9Primary Myelofibrosis 8Lymphoma, Non-Hodgkin 7Leukemia, Biphenotypic, Acute 7Neuroblastoma 6Myeloproliferative Disorders 6Lymphoma 6Hodgkin Disease 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Large B-Cell, Diffuse 4Ganglioneuroblastoma 4Polycythemia Vera 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia 3Hematologic Neoplasms 3Thrombocythemia, Essential 2Rhabdomyosarcoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Graft vs Host Disease 2Anemia, Aplastic 2Wilms Tumor 1

Interventions

Specimen Handling 4lutetium Lu 177 dotatate 3gallium Ga 68 dotatate 3Magnetic Resonance Spectroscopy 3olaparib 2cabozantinib 2belzutifan 2Temozolomide 2Nivolumab 2Fluorodeoxyglucose F18 2Biopsy 26-fluorodopamine 23-Iodobenzylguanidine 2tipifarnib 1talazoparib 1spartalizumab 1pembrolizumab 1pegfilgrastim 1lanreotide 1guadecitabine 1fluorodopa F 18 1fludarabine phosphate 1copper dotatate CU-64 1atezolizumab 1Stem Cell Transplantation 1Phenoxybenzamine 1Lutetium-177 1Lutetium 1Ipilimumab 1Interleukin-13 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × Stem Cell Transplantation × 1 year × Clear all
NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
15 enrolled
CNSEndocrine

Neuroblastoma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡